Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linus Haberbosch

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Deutsche Medizinische Wochenschrift (1946)|June 1, 2021
[New Developments in Type 1 Diabetes]Linus Haberbosch, Joachim Spranger
Reviews in Endocrine & Metabolic Disorders|June 17, 2026
Functional pituitary adenoma imagingLinus Hesse, Linus Haberbosch
Archives of Medical Research|September 2, 2023
Efficacy and Safety of Pegvisomant in the Treatment of AcromegalyLinus Haberbosch, Christian J Strasburger
MMW Fortschritte Der Medizin|February 11, 2022
[LAL-D - underdiagnosed, but important]Ursula Kassner, Linus Haberbosch, Friederike Schumann
European Journal of Endocrinology|June 14, 2025
Diagnostic Strategies for Central Adrenal Insufficiency in Clinical Practice: Authors' responseLinus Haberbosch, Christian J Strasburger, Lukas Maurer, et al.
Schmerz (Berlin, Germany)|December 12, 2022
[Transcranial alternating current stimulation to modulate oscillations in pain disorders]Jan D Wandrey, Mina Kandić, Linus Haberbosch, et al.
Nutrition & Diabetes|September 20, 2023
5-Aminovaleric acid betaine predicts impaired glucose metabolism and diabetesLinus Haberbosch, Sylwia Kierszniowska, Lothar Willmitzer, et al.
Endocrinology, Diabetes & Metabolism Case Reports|November 3, 2025
The relevance of patient-reported outcome measures in hypopituitarism: HIV therapy adherence and suicidal ideations resolved by GH replacementLinus Hesse, Loreen Richter, Lukas Maurer, et al.
Hormones (Athens, Greece)|August 6, 2025
Predictive factors for surgical interventions following intravenous glucocorticoid pulse therapy in active moderate-to-severe thyroid eye diseaseAnna Giannakogeorgou, Dominik Spira, Lukas Maurer, et al.
Endocrine-Related Cancer|January 11, 2022
Spironolactone is associated with reduced mitotane levels in adrenocortical carcinoma patientsLinus Haberbosch, Lukas Maurer, Arvid Sandforth, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Deutsche Medizinische Wochenschrift (1946)|June 1, 2021
[New Developments in Type 1 Diabetes]Linus Haberbosch, Joachim Spranger
Reviews in Endocrine & Metabolic Disorders|June 17, 2026
Functional pituitary adenoma imagingLinus Hesse, Linus Haberbosch
Archives of Medical Research|September 2, 2023
Efficacy and Safety of Pegvisomant in the Treatment of AcromegalyLinus Haberbosch, Christian J Strasburger
MMW Fortschritte Der Medizin|February 11, 2022
[LAL-D - underdiagnosed, but important]Ursula Kassner, Linus Haberbosch, Friederike Schumann
European Journal of Endocrinology|June 14, 2025
Diagnostic Strategies for Central Adrenal Insufficiency in Clinical Practice: Authors' responseLinus Haberbosch, Christian J Strasburger, Lukas Maurer, et al.
Schmerz (Berlin, Germany)|December 12, 2022
[Transcranial alternating current stimulation to modulate oscillations in pain disorders]Jan D Wandrey, Mina Kandić, Linus Haberbosch, et al.
Nutrition & Diabetes|September 20, 2023
5-Aminovaleric acid betaine predicts impaired glucose metabolism and diabetesLinus Haberbosch, Sylwia Kierszniowska, Lothar Willmitzer, et al.
Endocrinology, Diabetes & Metabolism Case Reports|November 3, 2025
The relevance of patient-reported outcome measures in hypopituitarism: HIV therapy adherence and suicidal ideations resolved by GH replacementLinus Hesse, Loreen Richter, Lukas Maurer, et al.
Hormones (Athens, Greece)|August 6, 2025
Predictive factors for surgical interventions following intravenous glucocorticoid pulse therapy in active moderate-to-severe thyroid eye diseaseAnna Giannakogeorgou, Dominik Spira, Lukas Maurer, et al.
Endocrine-Related Cancer|January 11, 2022
Spironolactone is associated with reduced mitotane levels in adrenocortical carcinoma patientsLinus Haberbosch, Lukas Maurer, Arvid Sandforth, et al.
Pageof 3